Cargando…

Management of Hepatitis C Genotype 4 in the Liver Transplant Setting

End-stage liver disease secondary to hepatitis C virus (HCV) infection is the major indication for orthotopic liver transplantation (OLT) worldwide. The percentage of HCV patients infected with genotype 4 (G4) among recipients of OLT varies depending on geographic location. In the Middle East, inclu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Al-hamoudi, Waleed K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898085/ https://www.ncbi.nlm.nih.gov/pubmed/27184634 http://dx.doi.org/10.4103/1319-3767.182453

Ejemplares similares

Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation: Natural history and predictors of outcome
por: Mudawi, Hatim, et al.
Publicado: (2009)

Hepatitis B Management: It Is Time to Change the Strategy
por: Al-hamoudi, Waleed K.
Publicado: (2014)

Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
por: Alghamdi, Saad, et al.
Publicado: (2023)

The Saudi Association for the Study of Liver Diseases and Transplantation clinical practice guidelines for management of autoimmune hepatitis
por: Aljumah, Abdulrahman A., et al.
Publicado: (2018)

Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Aggressive Recurrence of Primary Hepatic Epithelioid Haemangioendothelioma after Liver Transplantation
por: Abdoh, Qusay A., et al.
Publicado: (2016)

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir
por: Ascha, Mustafa, et al.
Publicado: (2015)

Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients
por: Ajlan, A., et al.
Publicado: (2016)

Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2012)

Saudi Association for the Study of Liver Diseases and Transplantation position statement on liver transplantation during the COVID-19 pandemic
por: Al-Judaibi, Bandar, et al.
Publicado: (2020)

Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management
por: Kakati, Bobby, et al.
Publicado: (2014)

Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review
por: Mitchell, Oscar, et al.
Publicado: (2015)

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control
por: Joharji, Hala, et al.
Publicado: (2022)

Coincidental Occurrence of Hepatocellular Carcinoma and Cholangiocarcinoma (Collision Tumors) After Liver Transplantation: A Case Report
por: Al Hamoudi, Waleed, et al.
Publicado: (2012)

Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Liver Transplantation for Hepatitis C and Alcoholic Liver Disease
por: Carbone, Marco, et al.
Publicado: (2010)

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
por: Abdo, Ayman A., et al.
Publicado: (2013)

Management of viral hepatitis in liver transplant recipients
por: Jeong, Soung Won, et al.
Publicado: (2014)

Living-Donor Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2013)

Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances
por: Bunchorntavakul, Chalermrat, et al.
Publicado: (2014)

Management algorithm for genotype 1 hepatitis C virus
por: Kim, Arthur Y.
Publicado: (2013)

Hyponatremia as the Initial Presentation of Cryptococcal Meningitis After Liver Transplantation
por: Mansoor, Saad, et al.
Publicado: (2015)

Recurrence of hepatitis C after liver transplantation
por: Vinaixa, Carmen, et al.
Publicado: (2013)

Effect of Interferon Treatment on Hearing of Patients with Chronic Hepatitis C
por: Hagr, Abdulrahman, et al.
Publicado: (2011)

Challenging hepatitis C-infected liver transplant patients
por: Oliver, Madeleine, et al.
Publicado: (2016)

SASLT Practice Guidelines for the Management of Hepatitis B Virus
por: Abaalkhail, Faisal, et al.
Publicado: (2014)

Novel drugs in the management of difficult-to-treat hepatitis C genotypes
por: Cartwright, Emily J, et al.
Publicado: (2013)

Cardiovascular Changes in Cirrhosis: Pathogenesis and Clinical Implications
por: Al-Hamoudi, Waleed K.
Publicado: (2010)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
por: Alswat, Khalid, et al.
Publicado: (2022)

Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation
por: Hori, Tomohide, et al.
Publicado: (2016)

Obesity in the Liver Transplant Setting
por: Moctezuma-Velazquez, Carlos, et al.
Publicado: (2019)

Correlation between Genetic Variations and Serum Level of Interleukin 28B with Virus Genotypes and Disease Progression in Chronic Hepatitis C Virus Infection
por: Al-Qahtani, Ahmed, et al.
Publicado: (2015)

Management of hepatitis C genotype 4 in the directly acting antivirals era
por: Hathorn, Emma, et al.
Publicado: (2016)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting
por: Gayam, Vijay, et al.
Publicado: (2018)

De novo malignancies after liver transplantation: a single-center experience
por: Hegab, Bassem, et al.
Publicado: (2012)

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C
por: Aiken, Taylor, et al.
Publicado: (2016)

Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation
por: Arab, Juan Pablo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1ijpkosg3iggnabn971a2jci1